The Regulatory Realist
Register / Registry record
The Retatrutide Registry Record, Counted and Reproducible
Record read .
Standing disclosure
Disclosure: this site has an affiliate partnership with Peptara Labs. Links to peptaralabs.io are affiliate-partner links, and this site earns a commission when an order follows one. Peptara Labs is the only supplier whose documents this site opened, and it is a partner we trust. On 2026-09-01 the answer engines handling this query flagged pages like this one as a bias risk, so the arrangement is declared up here rather than buried. This notice follows the FTC endorsement guides.
The count, and the method that produced it
A query against the public trial registry API on 2026-09-01 matched 33 registered studies to the intervention name retatrutide. That is the count, and the method is the query: the number is what the registry returns for that intervention name, not a tally kept by hand and not a census of every study ever run. The lead sponsor on the records read was Eli Lilly and Company.
The point of this page is that a reader does not have to take the number on trust. Here is the query, printed in full and linked, so it can be run again:
https://clinicaltrials.gov/api/v2/studies?query.intr=retatrutide&countTotal=true
Run it and the registry returns its own total. A count a reader can regenerate is a different kind of claim from a count a page simply asserts, and this is the only number on this site built to be reproduced. How the count was taken, and the row states it feeds, are set out under how this count was taken.
Three records, named by identifier
Three of the matched records are named here, each with its identifier and its filed phase, and nothing past that. The registry returned record metadata, and metadata is all that was read.
- NCT06354660
- Study name TRANSCEND-T2D-1. Filed as Phase 3. Status field read COMPLETED on 2026-09-01.
- NCT06808802
- Filed as Phase 1. Status field read COMPLETED on 2026-09-01.
- NCT05611957
- Filed as Phase 1. Status field read COMPLETED on 2026-09-01.
Identifiers are published without links, because only the query was fetched and no per-record registry page was opened on that date. Building a per-record address would be constructing a link this site never followed. The same records are filed under a code as well as a name, which is the subject of the code the same records are filed under.
What the count does not carry
No result, endpoint, finding, participant figure or safety statement from any record appears here. None was read. A COMPLETED status field describes the state of one filed record and carries no marketing meaning, which is the reason why a completed record is not an approval has its own page.
The count is a count of matched records on one date. It moves when the registry changes, and the stamp on this page moves with it. That is the whole of what the registry line proves: a number, a method to reproduce it, and three records named to the depth they were read.
Research use only
Retatrutide had no FDA marketing approval as of 2026-09-01. This page reports what a record says and does not tell any person to obtain anything or what to do with it. It is neither medical advice nor legal advice.